This report evaluates the clinical utility of genetic testing for fragile X−associated tremor/ataxia syndrome (FXTAS). The goal of this report is to assess how genetic testing of men and women with clinical and/or radiologic features suggestive of FXTAS changes patient outcomes, alters diagnostic thinking, results in decision-making guidance, and/or leads to familial and societal impacts.
If you have a Hayes login, click here to view the full report on the Knowledge Center.